Literature DB >> 8161423

Acute traumatic intracerebral haematomas: determinants of outcome in a retrospective series of 202 cases.

M Choksey1, H A Crockard, M Sandilands.   

Abstract

A retrospective study was carried out of 202 patients with traumatic intracerebral haematomas (TICH) noted on CT, to determine which factors most affected outcome. There were 151 (75%) males and 51 (25%) females, whose ages ranged from 1 to 84 years. One-hundred-and-two (51%) had a good outcome (Glasgow Outcome Score 1 and 2). Thirty-five (17%) were vegetative or severely disabled and 65 (32%) died. Of the 169 with a single haematoma, 98 (58%) had a good outcome, while only 20% of patients with two clots fared well. No patient with three or more haematomas had a good outcome. Single factor logistic regression analysis identified Glasgow Coma Score (GCS), haematoma volume and difficulty with airway maintenance or poor arterial oxygenation as important factors in determining outcome. A four-factor logistic regression analysis model was developed which revealed that, when all other factors had been taken into consideration, craniotomy significantly improved the probability of a good outcome.

Entities:  

Mesh:

Year:  1993        PMID: 8161423     DOI: 10.3109/02688699308995090

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Moderate head injuries in children as compared to other age groups, including the cases who had talked and deteriorated.

Authors:  N Ceviker; K Baykaner; S Keskil; M Cengel; M Kaymaz
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  Imaging for the diagnosis and management of traumatic brain injury.

Authors:  Jane J Kim; Alisa D Gean
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Surgical trial in traumatic intracerebral hemorrhage (STITCH(Trauma)): study protocol for a randomized controlled trial.

Authors:  Barbara A Gregson; Elise N Rowan; Patrick M Mitchell; Andy Unterberg; Elaine M McColl; Iain R Chambers; Paul McNamee; A David Mendelow
Journal:  Trials       Date:  2012-10-16       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.